6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0014 770-24-4-801-0617 -National CMOP A1222 ACAMPROSATE
ID: 36C77025Q0014Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/8d13aa58fe794076b7009b9442b2c026/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking to procure Acamprosate Calcium 333mg EC tablets through an emergency solicitation, identified by the number 36C77025Q0014, for delivery to multiple locations within its Consolidated Mail Outpatient Pharmacy (CMOP) system. The procurement requires various quantities of the specified pharmaceutical, with a total of six different delivery amounts outlined, and adherence to the Drug Supply Chain Security Act is mandatory for all vendors. This acquisition is critical for ensuring that the VA can meet its pharmaceutical needs efficiently, supporting the health and well-being of veterans. Interested vendors must submit their quotes by October 10, 2024, at 9:00 AM CST, and are encouraged to contact Contracting Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov for further details.

    Point(s) of Contact
    McAlhaney, Michael W.Contract Specialist
    (913) 684-0134
    Michael.McAlhaney@va.gov
    Files
    Title
    Posted
    36C77025Q0014_1.docx
    The government document outlines a solicitation for pharmaceutical supplies by the Department of Veterans Affairs, specifically through the Network Contracting Office 15. The requisition includes details such as the contract number, solicitation number, and key dates for proposal submission. This procurement is set aside for small businesses, including HUBZone and veteran-owned entities. The document specifies requirements for delivery, which must adhere to USPS standards and include tracking information. Suppliers must provide detailed pharmaceutical information, including National Drug Codes (NDCs) and compliance with Drug Supply Chain Security Act (DSCSA) regulations. A thorough understanding of barcoding standards and delivery documentation is required to ensure traceability and quality assurance. Additionally, the solicitation emphasizes the importance of negotiation for price and product availability prior to order placement. Compliance with various federal acquisition regulations is mandatory, and the contractor must demonstrate adherence to post-order qualifications and guidelines. This solicitation underscores the government’s commitment to sourcing quality pharmaceutical products while supporting small businesses in the contracting process.
    36C77025Q0014.docx
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for an emergency procurement of various quantities of Acamprosate 333mg EC tablets, intended for delivery to multiple locations within its Consolidated Mail Outpatient Pharmacy (CMOP) system. The solicitation number for this request is 36C77025Q0014, with responses due by October 10, 2024, at 9:00 AM CST. This requirement falls under the Product Service Code 6505 and NAICS code 325412. Vendors must include a price schedule in Excel format, their state wholesale distributor license, and other specific documentation with their quotes. The delivery timeframe is set for 10 days after receipt of order, and all goods must adhere to the Drug Supply Chain Security Act. Interested parties are encouraged to monitor the SAM.gov website for any updates or amendments. The solicitation aims to ensure that the VA can meet its pharmaceutical needs efficiently while adhering to relevant trade agreement policies. All submissions must be made via email to the Contract Specialist, Michael McAlhaney, at the provided contact information. Compliance with regulations and clear documentation is critical for potential vendors.
    52.225-6 TRADE AGREEMENTS CERTIFICATE.docx
    The document outlines the Trade Agreements Certificate requirements for federal solicitations, emphasizing the certification of end products as U.S.-made or designated country products. Offerors must declare any non-compliant items and specify their country of origin. The government will assess offers based on the Federal Acquisition Regulation, specifically targeting U.S.-made or designated products, particularly for those covered under the WTO GPA, which allows evaluation without Buy American statute restrictions. The Contracting Officer may consider alternatives only if there are no suitable offers for compliant products. This provision reinforces the government's commitment to supporting domestic manufacturing while adhering to international trade agreements in procurement processes.
    S02_Solicitation_Attachment_Pricing SpreadSheet_RFQ_36C77025Q0014.xlsx
    The document details a Request for Quotation (RFQ) from the VA for a specific pharmaceutical, Acamprosate Calcium 333mg EC tablets in various quantities. The RFQ (36C77025Q0014) specifies an estimated issue date of October 3, 2024, with quotes due by October 10, 2024, and an estimated award date of October 16, 2024, with delivery expected by October 30, 2024. Vendors are required to comply with the Drug Supply Chain Security Act (DSCSA), ensuring they provide documentation verifying their licensing and compliance with U.S. regulations regarding prescription drug products. Key required documents include a signed solicitation cover page (SF1449), a price schedule in Excel format, a state wholesale distributor license, and a completed Trade Agreements Certificate. Vendors failing to submit the necessary documentation will be considered technically unacceptable. The RFQ emphasizes the VA's preference for electronic documentation formats to streamline compliance processes. The document serves as a guideline for potential suppliers to ensure adherence to regulatory standards while addressing the VA's procurement needs.
    Similar Opportunities
    6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    6505--770-24-4-801-0686 -National CMOP CLINDAMYCIN -(VA-24-00096153)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Clindamycin PO4 1% Top Swab for delivery to multiple Compounding Medication Outpatient Pharmacies (CMOP) across the country. This procurement aims to secure approximately 3,584 units of the specified pharmaceutical product, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). The goods are essential for the VA's healthcare services, supporting the treatment of various medical conditions. Interested vendors must submit their quotations by September 6, 2024, including a signed SF1449 cover page, a price schedule, proof of a valid State Wholesale Distributor License, and a Buy American Act Certificate. For further inquiries, vendors can contact Kelley Cunningham at kelley.cunningham@va.gov or call 913-684-0140.
    6505--CGRP Calcitonin Gene-Related Peptides
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Calcitonin Gene-Related Peptides (CGRP) to support various healthcare programs, including those for Consolidated Mail Order Pharmacies and State Veterans Homes. The contract will require the successful offeror to provide a consistent supply of specified CGRP products, which are critical for treating patients with certain medical conditions, ensuring uninterrupted access to these essential medications. The solicitation is expected to be released on or about October 10, 2024, with a closing date of October 24, 2024, and interested parties should direct inquiries to Contracting Officer Chris Carthron at Christopher.Carthron@va.gov or by phone at (708) 786-4980. The contract will span one year with four additional one-year options, and all relevant documents will be available electronically at sam.gov.
    6505--Bupropion Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the procurement of Bupropion Hydrochloride tablets to support veterans and related entities through its Pharmaceutical Prime Vendor (PPV) Programs. Offerors are required to submit pricing that includes a 0.5% Cost Recovery Fee and provide unique National Drug Code (NDC) numbers for their products, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and FDA regulations. This procurement is crucial for maintaining a reliable pharmaceutical supply for VA healthcare facilities, with a strong emphasis on participation from small and disadvantaged businesses. Interested parties should contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further details regarding submission requirements and deadlines.
    6505--Prasugrel HCL 5mg and 10mg 30 Count Bottles
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Prasugrel Hydrochloride (HCL) tablets in 5mg and 10mg 30-count bottles. The Request for Proposal (RFP) outlines specific requirements for offerors, including pricing for a base year and four optional one-year periods, compliance with federal regulations, and the provision of unique National Drug Code (NDC) numbers. This procurement is crucial for ensuring a reliable supply of essential medications to support veterans and related healthcare providers under the VA and Department of Defense's Pharmaceutical Prime Vendor Programs. Interested parties must submit their proposals by October 8, 2024, at 2:30 PM Central Standard Time, and can direct inquiries to Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov.
    8145--Medication Return Envelopes (VA-24-00012799)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Medication Return Envelopes under solicitation number 36C77024Q0051. This initiative aims to supply multiple Veterans Affairs Medical Centers (VAMCs) and Consolidated Mail Outpatient Pharmacies (CMOP) with a system for the safe disposal of scheduled and non-controlled medications over a five-year period, from November 2024 to October 2029. The program is critical for enhancing medication safety, preventing accidental overdoses, and reducing environmental waste, with an estimated budget of $47 million. Interested vendors must submit their bids by October 14, 2024, at 5 PM Central Time, and are encouraged to monitor SAM.gov for further solicitation details, which will be posted on September 13, 2024. For inquiries, contact Contract Specialist Diana Olson at Diana.Olson@va.gov or 913-684-0153.
    6505-- Duplex Antibiotic Supply IV Bags
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting quotes for Duplex Antibiotic Supply IV Bags under solicitation number 36C26225Q0028, aiming to establish a base contract for one year with four additional option years. The procurement requires the successful contractor to supply specific pharmaceutical products, including Cefazolin and Ceftriaxone, ensuring that all items meet the specified performance and regulatory standards. This contract is crucial for maintaining essential supplies for patient care within the VA healthcare system, with an estimated total contract value ranging from $150,000 to $300,000. Interested vendors must be registered in the System for Award Management (SAM) and submit any questions via email to Melissa Ramirez by October 8, 2024, with quotes due by October 11, 2024.
    R706--Reverse pharmaceutical distribution services. Questions and Answers for solicitation RFQ 36C26024Q0959 clarification Amendment 0001
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to provide reverse pharmaceutical distribution services under solicitation RFQ 36C26024Q0959. The primary objective of this procurement is to ensure the safe and compliant disposal of pharmaceutical products, including the management of liquidation-eligible and ineligible items, while adhering to federal regulations. This contract, valued at approximately $16.5 million, will span five years from November 1, 2024, to October 31, 2029, with responses due by October 10, 2024, at 13:00 Pacific Time. Interested vendors should direct inquiries to José Ronstadt at jose.ronstadt@va.gov or call 360-852-9885 for further clarification.
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking suppliers for Norethindrone 5mg Tablets under solicitation number VA-25-00005551. This procurement aims to secure pharmaceutical products essential for the healthcare of veterans, specifically focusing on the manufacturing of these tablets. Norethindrone is a critical medication used in various treatments, highlighting the importance of reliable supply in supporting veteran health services. Interested vendors should note that the offer due date has been extended to October 15, 2024, and can direct inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--Ketoconazole 2% Cream
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ketoconazole 2% Cream, which will serve various federal healthcare services, including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The procurement aims to ensure an uninterrupted supply of this pharmaceutical product, with a contract period of one year and four optional one-year extensions. The estimated annual requirements include approximately 62,643 tubes of 15 GM, 233,385 tubes of 30 GM, and 139,890 tubes of 60 GM. Interested vendors should note that the solicitation is expected to be released around October 10, 2024, with a response deadline of October 24, 2024, and can direct inquiries to Michael Olszewski at michael.olszewski@va.gov.